Distributor inventory
Voglibose 0.3 mg + Metformin (strength unknown)
Type 2 diabetes mellitus (as add-on to diet and exercise) to improve post-meal and overall blood glucose control
Voglibose is an alpha-glucosidase inhibitor that delays digestion and absorption of carbohydrates in the intestine, reducing post-meal blood sugar spikes. Metformin lowers glucose production in the liver and improves insulin sensitivity, helping the body use glucose more effectively.
Oral tablets. Take exactly as prescribed. Voglibose-containing combinations are usually taken just before meals/with the first bite of food to reduce postprandial glucose; metformin is typically taken with meals to reduce stomach upset. Swallow whole with water.
Common side effects of VOGLIDYN M 0.3 may include:
Not for type 1 diabetes or diabetic ketoacidosis. Metformin: risk of lactic acidosis (rare but serious)—use caution in kidney or liver impairment, dehydration, severe infection, hypoxia, heart failure, and in the elderly; stop temporarily before/after iodinated contrast procedures and major surgery as advised. Voglibose: may cause GI side effects; avoid/use caution in inflammatory bowel disease, intestinal obstruction/ulceration, or chronic intestinal disorders. Monitor blood glucose, HbA1c, renal function; long-term metformin can cause vitamin B12 deficiency. If hypoglycemia occurs (especially with insulin/sulfonylureas), treat with glucose (not sucrose).
